Saroasis Studios Reveals Fate Trigger Early Access Date
COLOGNE, Germany, Aug. 22, 2025 /PRNewswire/ -- Following a highly successful Closed Beta Test that drew in over hundreds of thousands of players shortly after launch, Saroasis Studios officially announced the Early Access release date for its flagship title, Fate Trigger, set for 2026 Q1.
This Cisco Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday - BJ's Wholesale Club Hldgs ( NYSE:BJ ) , Applied Industrial Techs ( NYSE:AIT )
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Citigroup analyst David Lebowitz downgraded the rating for Schrödinger, Inc.
This AZZ Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday - AZZ ( NYSE:AZZ ) , Nucor ( NYSE:NUE )
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Barclays analyst Peter Lawson initiated coverage on Schrödinger, Inc.
Schrodinger, Inc. ( SDGR ) Reports Q2 Loss, Beats Revenue Estimates
Schrodinger (SDGR) delivered earnings and revenue surprises of +28.92% and +5.08%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Schrödinger ( SDGR ) Q2 2025 Earnings Transcript
Image source: The Motley Fool.Wednesday, August 6, 2025 at 8:30 p.m. ETChief Executive Officer - Ramy FaridContinue reading ...
Clover Health Investments, Corp. ( CLOV ) Q2 Earnings Meet Estimates
Clover Health Investments (CLOV) delivered earnings and revenue surprises of 0.00% and -1.01%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Can Veeva's Vault R&D Keep Its Lead Amid Rising AI Competition?
VEEV leans on Vault R&D for growth as AI-native rivals rise, testing its edge in clinical and regulatory innovation.
RXRX vs. RLAY: Which Precision Biotech Stock is a Better Bet Now?
Recursion Pharmaceuticals and Relay Therapeutics both leverage their respective AI drug discovery platforms to potentially develop novel therapeutic candidates.
Analysts Estimate Omnicell ( OMCL ) to Report a Decline in Earnings: What to Look Out for
Omnicell (OMCL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Can Recent Pipeline Expansion Efforts Offset RXRX's Earlier Losses?
Recursion Pharmaceuticals bets on REC-4881, cancer candidates and new hypophosphatasia therapy to rebuild momentum after key drug cuts rattled investors.
Schrodinger, Inc. ( SDGR ) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
Schrodinger (SDGR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Can Recursion Pharmaceuticals' Strategic Deals Fuel Long-Term Growth?
RXRX is scaling its AI-driven drug discovery technology through billion-dollar pharma deals and strategic tech alliances.
Will RXRX's Shift in Pipeline Focus Help Restore Investor Faith?
Recursion Pharmaceuticals axes three drug programs after weak study data, but shifts focus to more promising candidates like REC-4881 to regain ground.
Can RXRX's AI-Based Approach Revolutionize the Drug Discovery Process?
Recursion Pharmaceuticals is transforming drug discovery with AI-driven RecursionOS, slashing costs and boosting development speed.
VEEV Integrates GenAI in Vault Platform to Drive Workflow Automation
Veeva's new AI layer in Vault boosts automation and deepens pharma reliance, sharpening its edge in life sciences tech.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Schrödinger, Inc. - SDGR - Schrodinger ( NASDAQ:SDGR )
NEW YORK, June 15, 2025 ( GLOBE NEWSWIRE ) -- Pomerantz LLP is investigating claims on behalf of investors of Schrödinger, Inc. ( "Schrödinger" or the "Company" ) SDGR. Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Schrödinger, Inc. - SDGR - Schrodinger ( NASDAQ:SDGR )
NEW YORK, June 02, 2025 ( GLOBE NEWSWIRE ) -- Pomerantz LLP is investigating claims on behalf of investors of Schrödinger, Inc. ( "Schrödinger" or the "Company" ) SDGR. Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
RXRX vs. SDGR: Which AI-Powered Drug Discovery Stock Has More Upside?
Recursion Pharmaceuticals and Schrodinger leverage their respective AI drug discovery platforms to potentially develop distinguished therapeutic candidates.
Schrodinger, Inc. ( SDGR ) Reports Q1 Loss, Tops Revenue Estimates
Schrodinger (SDGR) delivered earnings and revenue surprises of -15.49% and 6.81%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Standard BioTools ( LAB ) Reports Q1 Loss, Tops Revenue Estimates
Standard BioTools (LAB) delivered earnings and revenue surprises of 0% and 1.73%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Fulgent Genetics, Inc. ( FLGT ) Q1 Earnings and Revenues Beat Estimates
Fulgent Genetics (FLGT) delivered earnings and revenue surprises of 121.05% and 2.76%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Cathie Wood Bets Against Mark Zuckerberg's Meta Ahead Of Crucial Earnings Report, Loads Up On This Amazon Rival - Advanced Micro Devices ( NASDAQ:AMD ) , ARK Innovation ETF ( BATS:ARKK )
On Tuesday, Cathie Wood-led Ark Invest executed notable trades involving Meta Platforms Inc. META , Advanced Micro Devices Inc. AMD, and Shopify Inc. SHOP. The Meta Platforms Trade saw Ark Invest offloading 2,865 shares of Meta Platforms Inc. through its ARK Innovation ETF ARKK fund.
Cathie Wood Chops Palantir: Ark Invest Dumps $9.1 Million Worth Of Stock, Also Sells Meta And Robinhood Shares - Advanced Micro Devices ( NASDAQ:AMD ) , ARK Innovation ETF ( BATS:ARKK )
On Monday, Cathie Wood's Ark Invest executed several significant trades, including the sale of shares in Palantir Technologies Inc. PLTR, Robinhood Markets Inc. HOOD and Meta Platforms Inc. META, while also acquiring shares in Advanced Micro Devices Inc. AMD and Baidu Inc.
Nvidia-Backed Recursion, Ginkgo Bioworks Rally Following FDA's Decision To End Animal Testing - Absci ( NASDAQ:ABSI ) , Charles River ( NYSE:CRL )
The U.S. Food and Drug Administration ( FDA ) announced its plans to end the mandatory animal testing of new drugs, a move that sent AI-enabled biotech companies such as Recursion Pharmaceuticals Inc. RXRX and Ginkgo Bioworks Holdings Inc. DNA rallying last week.
Schrodinger ( SDGR ) Moves 27.4% Higher: Will This Strength Last?
Schrodinger (SDGR) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.
Recursion Pharmaceuticals Shares Are Up Today: what's Going On? - Recursion Pharmaceuticals ( NASDAQ:RXRX )
he FDA is officially moving away from mandatory animal testing in drug development, opting instead for AI-driven models. Recursion Pharmaceuticals and other AI-focused biotech companies saw sharp share price increases-between 15% and 25%.
Fastenal Posts Better-Than-Expected Sales, Joins Simulations Plus, Certara And Other Big Stocks Moving Higher On Friday - Amarin Corp ( NASDAQ:AMRN ) , Absci ( NASDAQ:ABSI )
U.S. stocks were lower, with the Dow Jones index dipping over 250 points on Friday. Shares of Fastenal Company FAST rose sharply during Thursday's session following better-than-expected first-quarter sales.
Health Care Technology Stocks Surge After FDA Announces Plans To Phase Out Animal Testing Requirements - Absci ( NASDAQ:ABSI ) , Certara ( NASDAQ:CERT )
The FDA will phase out animal testing in favor of AI-based computational models of toxicity and cell lines and organoid toxicity testing. "This initiative marks a paradigm shift in drug evaluation," the FDA says.
World Quantum Day Heat: IONQ To Ring The Bell, DARPA Boost Tempts Bulls - IonQ ( NYSE:IONQ )
IonQ gains DARPA nod, rings NYSE bell, and expands quantum presence globally. Technicals lean bullish, but stock faces resistance at 50-day average despite recent momentum. Feel unsure about the market's next move? Copy trade alerts from Matt Maley-a Wall Street veteran who consistently finds ...
Just 3 Stocks Make Up 65% of the Bill & Melinda Gates Foundation Portfolio. Should They Be a Part of Yours?
Celebrating its 25th anniversary this year, the Bill & Melinda Gates Foundation is one of the largest philanthropic organizations in the world. To support its efforts at facilitating improvements in the lives of people around the world, the foundation, which has provided more than $77 billion in ...
The Quantum Sandbox: How AI + QC Changes Everything
SandboxAQ is a unique private research firm spun-out of Google that specializes in synthesizing AI and Quantum Computing.
Schrodinger, Inc. ( SDGR ) Reports Q4 Loss, Tops Revenue Estimates
Schrodinger (SDGR) delivered earnings and revenue surprises of -57.14% and 5.79%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Pulmonx Corporation ( LUNG ) Reports Q4 Loss, Tops Revenue Estimates
Pulmonx (LUNG) delivered earnings and revenue surprises of 23.26% and 4.95%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Schrodinger ( SDGR ) Moves 14.1% Higher: Will This Strength Last?
Schrodinger (SDGR) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Seagate Posts Upbeat Earnings, Joins Netflix, Travelers, Teledyne Technologies And Other Big Stocks Moving Higher On Wednesday - Absci ( NASDAQ:ABSI ) , ARM Holdings ( NASDAQ:ARM )
U.S. stocks were higher, with the Dow Jones index gaining over 100 points on Wednesday. Shares of Seagate Technology Holdings plc STX rose sharply during Wednesday's session after the company reported second-quarter EPS and revenues above analyst estimates.
2 No-Brainer Quantum Computing Stocks to Buy Right Now
Quantum computing is taking off, but how long will it take, and which stocks should you consider? Two leaders in the space stand out as great investments today.
Cathie Wood Keeps Betting On Amazon's 'Haul' Play: Ark Loads Up $6M Worth Of Shares - Archer Aviation ( NYSE:ACHR ) , Advanced Micro Devices ( NASDAQ:AMD )
On Thursday, Ark Invest, led by Cathie Wood, made significant trades in Amazon.com Inc. AMZN and Rocket Lab USA Inc. RKLB, according to the firm's daily trade data.
Cathie Wood Cashes Out On Rocket Lab's 28% Surge in $9M Share Sale But Expands Bet On Flying Cars - Archer Aviation ( NYSE:ACHR ) , Advanced Micro Devices ( NASDAQ:AMD )
On Wednesday, the Cathie Wood-led Ark Invest made substantial trades in Rocket Lab USA Inc RKLB, Amazon.com Inc AMZN, and Archer Aviation ACHR.
Schrödinger Scores Big Despite Q3 Miss As Novartis Collaboration Promises Billions In Milestones: Details - Schrodinger ( NASDAQ:SDGR )
Schrodinger, Inc. SDGR shares are trading higher on Tuesday. The company disclosed a research collaboration and license agreement with Novartis AG NVS to advance multiple development candidates.
Schrodinger, Inc. ( SDGR ) Reports Q3 Loss, Misses Revenue Estimates
Schrodinger (SDGR) delivered earnings and revenue surprises of -30% and 13.85%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
The Joint Corp. ( JYNT ) Q3 Earnings Match Estimates
The Joint (JYNT) delivered earnings and revenue surprises of 0% and 5.49%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Drug Discovery Informatics Market Size Set to Surpass USD 6.8 Billion by 2031 with 10.9% CAGR as AI Revolutionizes Data Analysis in Drug Development | Transparency Market Research, Inc.
Wilmington, Delaware, United States, Transparency Market Research Inc. - , Nov. 04, 2024 ( GLOBE NEWSWIRE ) -- The global drug discovery informatics market ( 약물 발견 정보학 시장 ) is estimated to flourish at a CAGR of 10.9% from 2023 to 2031.
Omnicell ( OMCL ) Beats Q3 Earnings and Revenue Estimates
Omnicell (OMCL) delivered earnings and revenue surprises of 36.59% and 1.57%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
3 Key Trends That Are Bullish for Recursion Pharmaceuticals Stock
This company stands to benefit from a shifting pharmaceutical industry landscape.
iRhythm Technologies ( IRTC ) Soars 21.7%: Is Further Upside Left in the Stock?
iRhythm Technologies (IRTC) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
"Rule Breaker Investing" Gotta Know The Lingo, Vol. 6
We kick off the learning by talking about "risk capacity." ...
Schrodinger, Inc. ( SDGR ) Reports Q2 Loss, Tops Revenue Estimates
Schrodinger (SDGR) delivered earnings and revenue surprises of 12.94% and 17.78%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Omnicell ( OMCL ) Expected to Beat Earnings Estimates: Should You Buy?
Omnicell (OMCL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Earnings Preview: Schrodinger, Inc. ( SDGR ) Q2 Earnings Expected to Decline
Schrodinger (SDGR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Eli Lilly's First Biotech Deal Of 2024, Buys Chronic Disease Player Morphic For $3.2B Why Is Morphic Holding ( MORF ) Stock Jumping Today? - Morphic Holding ( NASDAQ:MORF ) , Eli Lilly and Co ( NYSE:LLY )
Monday, Eli Lilly And Co LLY agreed to acquire Morphic Holding Inc MORF for $57 per share in cash, an aggregate of approximately $3.2 billion. Morphic is a biopharmaceutical company developing a portfolio of oral integrin therapies for chronic diseases, including autoimmune, cardiovascular, and ...
